TrialBJU international2020

Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study.

Masaki Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.